Fitbit Collaborates with Scripps Research and Stanford Medicine to Study the Role of Wearables to Detect, Track and Contain Infectious Diseases like COVID-19

▤ Summary

“ From our previously published work, we know that data collected from consumer wearables can significantly improve the prediction of influenza-like illness,” said Dr. Eric Topol, Director and Founder, Scripps Research Translational Institute. “ We see an enormous opportunity to enhance disease tracking for improved population health during the COVID-19 pandemic, and are pleased to join this new consortium to bring value to the research community.” The Stanford Healthcare Innovation lab launched the COVID-19 wearables study, led by Michael Snyder, PhD, Chair of the Department of Genetics and Director of the Center for Genomics and Personalized Medicine at the Stanford University School of Medicine. The study aims to establish whether data collected from wearables, including Fitbit devices, can be used to predict the onset of an infectious disease such as COVID-19 before the actual symptoms start. “ Through this consortium, we’ll coordinate efforts to improve our understanding of how technology can serve to benefit human health, and continue the pioneering work we’ve led for the past decade exploring the promise of personalized medicine to predict and prevent disease.” Key elements of the new research consortium include: Fitbit users can easily access information on how to participate in these studies through the new COVID-19 Resource tab within the Fitbit mobile app, which also features tools and content to help users stay healthy, safe, and happy at home. Users also can virtually connect with a doctor directly from the Fitbit app via telemedicine provider PlushCare and stay up to date on the latest information with easy access to real-time updates from the World Health Organization.

▦ Linked Companies

Twine Health

$25M to $50M